twoXAR Media

• Publications
• Press Releases
• Feature Articles
• Media Mentions
• Events

Synergistic drug combinations from electronic health records and gene expression

Yen S Low, Aaron C Daugherty, Elizabeth A Schroeder, William Chen, Tina Seto, Susan Weber, Michael Lim, Trevor Hastie, Maya Mathur, Manisha Desai, Carl Farrington, Andrew A Radin, Marina Sirota, Pragati Kenkare, Caroline A Thompson, Peter P Yu, Scarlett L Gomez, George W Sledge Jr, Allison W Kurian, Nigam H Shah. Journal of the American Medical Informatics Association. EPub: December 9, 2016

Poster: An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis

Aaron C Daugherty¹, Carl Farrington¹, Isaac Hakim¹, Elizabeth S Noblin¹, Andrew M Radin¹, Mei-Sze Chua², Mark Rabe³, Guy Fernald³, Daniel Ford³, Marina Sirota⁴, Laura Schaevitz³, Andrew A Radin¹

¹twoXAR, ²Stanford University School of Medicine, ³Vium, ⁴UCSF

Download Poster (PDF)

Download Supplementary Material (PDF)

June 28, 2017

MIT Startup Exchange Names twoXAR to STEX25

June 19, 2017
twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate

May 15, 2017

twoXAR Appoints Brian Moriarty as CFO and Jill Jene, PhD, as SVP, Business Development

May 3, 2017

twoXAR to Present Data from In Vivo Studies Investigating New Rheumatoid Arthritis Drug Candidates at IMMUNOLOGY 2017

April 10, 2017

twoXAR Appoints Distinguished Researchers to New Scientific Advisory Board

March 14, 2017
twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate

February 23, 2017

Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

December 9, 2016

Study reveals drug interactions that may reduce mortality in breast cancer patients

October 4, 2016

twoXAR Collaborates with Researchers at Mount Sinai to Advance New Medicines for Diabetic Nephropathy

September 8, 2016

twoXAR Sets Sights on Liver Cancer With New Collaboration

June 14, 2016

twoXAR Completes Initial Studies of New Rheumatoid Arthritis Drug Candidates

May 25, 2016

twoXAR Enters Research Collaboration with the University of Chicago Department of Medicine to Investigate New Atherosclerosis Medicines

April 28, 2016

twoXAR Joins Hunt for Medicines Targeting Rare Skin Diseases

November 18, 2015

Andreessen Horowitz Leads $3.4M Investment in twoXAR to Accelerate Discovery of New Medicines

June 24, 2015

twoXAR Accelerates Digital Assault on Drug Discovery With Support From Stanford-Backed StartX Med Program

June 2, 2017

Gormley’s Take: Punching Back at Liver Cancer

March 29, 2017

Supercomputers Are Stocking Next Generation Drug Pipelines

March 29, 2017

March 19, 2017

TwoXAR merges artificial intelligence, drug discovery and… clones?

March 13, 2017

Silicon Valley Computational Drug Startup Takes on Glaucoma

December 9, 2016

Study reveals drug interactions that may reduce mortality in breast cancer patients

October 27, 2016

The Bio Report Podcast: How TwoXAR Is Using Big Data to Accelerate Drug Discovery

September 28, 2016

Bringing Big Data to Drug Discovery

September 23, 2016

Asian Liver Center collaborates with algorithm creator on HCC

September 12, 2016

Stanford inks computer-driven liver cancer drug discovery pact with twoXAR

September 8, 2016

Stanford University, TwoXar Extend Collaboration to Include Liver Cancer

September 1, 2016

Pharm Exec's Emerging Pharma Leaders 2016 - The Software Stylists

June 14, 2016

a16z Podcast: Move Fast But Don’t Break Things (When It Comes to Computational Biology)

May 27, 2016

A16z-Backed twoXAR Strikes Software-driven Drug Discovery Pact

May 19, 2016

Asian Leadership Conference: "Innovation in Entrepreneurship" Panel

May 6, 2016

Two Andrews and an Algorithm Aim to Accelerate Drug Discovery

April 1, 2016

Mission Possible: Software-driven Drug Discovery

February 22, 2016

Disrupting Drug Discovery - Article

Discovering New Drugs without the Wet Lab - Videos

February 18, 2016

A need for speed

January 25, 2016

Two Andrews take Twoxar toward accelerated drug discovery

January 19, 2016

Accelerating Drug Discovery Through Data Analysis

December 1, 2015

Bioinformatics Startup TwoXar Building Business Around Computational Drug Discovery Services

November 18, 2015

twoXAR Grabs $3.4M for Algorithm-Based Drug Discovery

November 18, 2015

Drug Discovery Startup TwoXar Raises $3.4M

September 30, 2015

Improving Health Through Computation

September 24, 2015

Accelerating Drug Discovery with Machine Learning on Big Medical Data

August 31, 2015

Entrepreneurs with the same name team up to share a startup as well

June 1, 2015

How twoXAR Plans to Radicalize the Drug Industry, One Data Set at a Time

July 12, 2017

AI-powered drug discovery captures pharma interest

July 1, 2017

Big pharma turns to AI to speed drug discovery, GSK signs deal​

June 21, 2017

Andreessen Horowitz Adds General Partners for Bio Fund

January 20, 2017

Hopes in the Machine

January 23, 2017

Chemists pin hopes on deep learning for drug discovery

January 11, 2016

AI 100: The Artificial Intelligence Startups Redefining Industries

December 6, 2016

Four Biomed Tech Game Changers From TEDMED

October 26, 2016

Stopping Breast Cancer with Help from AI

October 21, 2016

The Hopeful Future of Precision Medicine

July 25, 2016

Big data's big challenges in drug discovery

January 3, 2016

Venture capitalist is investing in firms that use computers to improve healthcare

December 31, 2015

Increased Competition, Investments Among Hallmarks of Bioinformatics Market in 2015

December 7, 2015

Five Pharma Startups that Made Headlines This Year

December 4, 2015

Notable Silicon Valley VC Firm Launches New Biotech Fund

November 25, 2015

New Bio Fund Partner Describes A16Z Investment Strategy

November 20, 2015

Andreessen Horowitz places $200M bet on the confluence of IT and biotech

November 19, 2015

Silicon Valley VC shop Andreessen Horowitz sets up $200M bio fund

November 18, 2015

Venture firm Andreessen Horowitz launches $200 million Bio Fund

November 18, 2015

Andreessen Horowitz raises $200M bio fund

November 18, 2015

Andreessen Horowitz Starts Health Care Fund

November 18, 2015

Andreessen Horowitz Launches $200M Bio-Computer Fund, Hires Ex-Stanford Prof

November 18, 2015

A top Silicon Valley VC firm is investing $200M in health software startups

November 18, 2015

Andreessen Horowitz launches $200M ‘bio fund’ to bridge gap between tech and biotech

November 18, 2015

Andreessen Horowitz Gets A New GP, And A New Fund

November 18, 2015

With $200 Million, Andreessen Horowitz Hopes To Digitize Biology

June 26-27, 2017

AI in Healthcare Summit 2017

May 12-16, 2017

Immunology 2017

April 24, 2017

Stanford Drug Discovery Conference

April 2-6, 2017

253rd American Chemical Society - National Meeting & Exposition

November 30 - December 2, 2016

twoXAR Presents What if new medications could be found in minutes instead of years?

October 9 - 11, 2016

twoXAR Discusses Driving Life Science Research Through Data Science

May 18, 2016

twoXAR Discusses Starting Up From Universities: MIT & Stanford

October 5, 2015 at 10:15am PT

twoXAR Discusses Biopharma Partnerships at Fall Health 2.0 Conference

September 16, 2015

twoXAR Presents at 2015 MIT Digital Health Conference

February 26, 2015

twoXAR Presents at 2015 MIT Sloan Bioinnovations Conference